Clinical Trials Directory

Trials / Completed

CompletedNCT04455204

Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in Preeclampsia

Implication of Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in the Pathogenesis of Preeclampsia and in Pregnancy Related Complications

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Tanta University · Academic / Other
Sex
Female
Age
25 Years – 35 Years
Healthy volunteers

Summary

The aim of the present study is to evaluate the implication of adipokines, inflammation, insulin resistance and endothelial dysfunction in the pathogenesis of preeclampsia and in pregnancy related complications.

Detailed description

This observational parallel study will be conducted on pregnant women with normal pregnancy, pregnant women with Preeclampsia, and on healthy non-pregnant women. All participants will be recruited from the Outpatient Clinic of Obstetrics and Gynecology Department at Menoufia University Hospital (Shebin El-Kom, Egypt). The study will be approved by the Research Ethics Committee of Menoufia University and all the involved subjects will give their written informed consent. This study will involve a total number of 60 women who will be further classified into: 20 non-pregnant women who serve as the control group (group 1), 20 pregnant women with normal pregnancy at their third trimesters (group 2) and 20 pregnant women with Preeclampsia at their third trimester (group 3) will be screened to fit the inclusion and exclusion criteria. The pregnant women will be assessed in their third trimesters and further re-evaluated 4 weeks after delivery. The gestational ages will be determined conventionally and re-affirmed by ultrasonographic measurement.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSerum asymmetteric dimethyl arginineSerum asymmetteric dimethyl arginine (ADMA) will be done using Enzyme-Linked Immunosorbent Assay
DIAGNOSTIC_TESTserum lipid profilesserum lipid profiles including triglycerides (TG), total cholesterol and high-density lipoprotein cholesterol (HDL-C) which will be measured by enzymatic colorimetric method) using commercial kits
DIAGNOSTIC_TESTSerum vaspinvaspin concentrations will be assayed using commercially available ELISA kits
DIAGNOSTIC_TESTSerum resistinresistin concentrations will be assayed using commercially available ELISA kits

Timeline

Start date
2016-04-25
Primary completion
2019-09-30
Completion
2019-10-01
First posted
2020-07-02
Last updated
2020-07-07

Source: ClinicalTrials.gov record NCT04455204. Inclusion in this directory is not an endorsement.